Transgene SA
TRGNF
$0.85
-$0.15-15.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.28% | -32.98% | -61.58% | -54.55% | -52.26% |
| Total Depreciation and Amortization | 8.11% | 2.15% | -2.27% | -12.11% | -18.48% |
| Total Amortization of Deferred Charges | -- | -86.34% | -83.94% | -83.94% | -83.94% |
| Total Other Non-Cash Items | 233.79% | 115.52% | 93.94% | 87.24% | 80.52% |
| Change in Net Operating Assets | -145.13% | 38.98% | 307.14% | 277.24% | 252.45% |
| Cash from Operations | -64.59% | -4.75% | 34.83% | 34.76% | 32.09% |
| Capital Expenditure | 70.99% | 65.02% | 58.85% | 26.24% | -14.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80,291.93% | -727.57% | -105.49% | -102.05% | -100.38% |
| Cash from Investing | -3,462.13% | -1,080.31% | -115.49% | -111.09% | -109.28% |
| Total Debt Issued | -- | -98.50% | -98.50% | -98.50% | -- |
| Total Debt Repaid | 98.63% | 96.42% | 94.85% | 54.78% | -4.03% |
| Issuance of Common Stock | 94,595.50% | 94,695.50% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.38% | 37.95% | 106.90% | 115.03% | 123.61% |
| Cash from Financing | 433.95% | 194.03% | -11.16% | 25.91% | 136.86% |
| Foreign Exchange rate Adjustments | -319.22% | -330.44% | -354.69% | -142.38% | 11,473.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,174.83% | -174.76% | -87.47% | -89.26% | -91.08% |